Details for New Drug Application (NDA): 087859
✉ Email this page to a colleague
NDA 087859 describes SPS, which is a drug marketed by Cmp Pharma Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the SPS profile page.
The generic ingredient in SPS is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
The generic ingredient in SPS is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 087859
| Tradename: | SPS |
| Applicant: | Cmp Pharma Inc |
| Ingredient: | sodium polystyrene sulfonate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 087859
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SPS | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 087859 | ANDA | CMP Pharma, Inc. | 46287-006 | 46287-006-01 | 473 mL in 1 BOTTLE (46287-006-01) |
| SPS | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 087859 | ANDA | CMP Pharma, Inc. | 46287-006 | 46287-006-04 | 120 mL in 1 BOTTLE (46287-006-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL, RECTAL | Strength | 15GM/60ML | ||||
| Approval Date: | Dec 8, 1982 | TE: | AA | RLD: | Yes | ||||
Complete Access Available with Subscription
